D. Patil et al.
1H NMR (300 MHz, CDCl3): d 11.89 (s, 1H, NH), 8.42-
8.37 (m, 2H, Ar–H), 7.39–7.37 (d, 1H, J = 8.1 Hz, Ar–H),
7.26–7.18 (m, 1H, Ar–H), 5.53 (s.1H, CH), 2.50–2.19 (m,
8H, CH2), 1.23 (s, 6H, CH3), 1.11 (s, 6H, CH3); 13C NMR
(75 MHz, CDCl3): d 190.8, 189.4, 148.6, 147.0, 134.4,
133.7, 122.9, 114.6, 46.9, 31.3, 31.0, 29.6, 27.3; ESI–MS
(m/z): 351.15 (M?H)?;
2.5.4 3,3,6,6-Tetramethyl-9-(3,4-dimethoxyphenyl)-
3,4,6,7,9,10-hexahydroacridine-1,8-dione (4n)
Yellow solid; mp 286–290 ꢁC; IR (KBr): 3273, 3200,
3071, 2954, 1642, 1610 cm-1
;
1H NMR(300 MHz, CDCl3): d 7.69 (s, 1H, NH), 6.92-
6.91 (d, 1H, J = 1.8 Hz, Ar–H), 6.84–6.81 (m, 1H, Ar–H),
6.68–6.65 (d, 1H, J = 8.4 Hz, Ar–H), 5.04 (s, 1H, CH),
3.80 (s, 3H, OCH3), 3.74 (s, 3H, OCH3), 2.31–2.12 (m, 8H,
CH2), 1.05 (s, 6H, CH3), 0.96 (s, 6H, CH3);
Anal. Calcd. for C22H26N2O2 (350.454): C, 75.40; H,
7.48; N, 7.99. Found: C, 75.31; H, 7.44; N, 8.05.
13C NMR (75 MHz, CDCl3): d 195.8, 148.7, 148.4,
147.1, 139.4, 119.8, 113.2, 111.8, 110, 55.7, 55.6, 50.8,
40.7, 32.9, 32.5, 29.5, 26.9; ESI–MS (m/z): 432.15
(M?Na)?;
2.5.8 3,3,6,6-Tetramethyl-9-(2-hydroxyphenyl)-
3,4,6,7,9,10-hexahydroacridine-1,8-dione (4s)
Yellow solid; mp [300 ꢁC; IR (KBr): 3405, 3265, 3083,
2943, 1649 cm-1
;
Anal. Calcd. for C25H31NO4 (409.571): C, 73.32; H,
7.63; N, 3.42. Found: C, 73.41; H, 7.72; N, 3.47.
1H NMR(300 MHz, DMSO-d6): d 9.64 (brs, 1H, OH),
9.48 (s, 1H, NH), 6.96–6.89 (m, 2H, Ar–H), 6.70–6.66 (m,
2H, Ar–H), 4.85 (s, 1H, CH), 2.52-2.03 (m, 8H, CH2), 1.02
(s, 6H, CH3), 0.90 (s, 6H, CH3); 13C NMR (75 MHz,
DMSO-d6): d 196.4, 153.6, 151.6, 134.4, 128.6, 127.4,
120.1, 117.7, 111.7, 50.3, 32.5, 29.3, 27.0, 26.9; ESI–MS
(m/z): 366.3 (M?H)?;
2.5.5 3,3,6,6-Tetramethyl-9-(3-trifluoromethylphenyl)-
3,4,6,7,9,10-hexahydroacridine-1,8-dione (4o)
Yellow solid; mp [300 ꢁC; IR (KBr): 3270, 3186, 3068,
2963, 1644, 1616 cm-1
;
1H NMR(300 MHz, DMSO-d6): d 8.92 (brs,1H,NH),
7.51–7.40 (m, 2H, Ar–H), 7.21–7.20 (d, 2H, J = 4.8 Hz,
Ar–H), 4.92(s, 1H, CH), 2.49–1.95 (m, 8H, CH2), 0.98 (s,
6H, CH3), 0.82 (s, 6H, CH3); 13C NMR (75 MHz, DMSO-
d6): d 195.2, 149.6, 148.1, 131.8, 128.1, 112.0, 50.6, 40.4,
40.3, 40.2, 39.9, 39.6, 39.3, 33.7, 32.4, 29.5, 26.7; ESI–MS
(m/z): 418 (M?);
Anal. Calcd. for C23H27NO3 (365.465): C, 75.59; H,
7.45; N, 3.83. Found: C, 75.54; H, 7.42; N, 3.87.
Table 1 Optimization solvent and reaction conditions for the syn-
thesis of acridinediones
Entry Solvent
Temp. (ꢁC) Time (min) Yield
(%)a
Anal. Calcd. for C24H26F3NO2 (417.463): C, 69.05; H,
6.28; N, 3.36. Found: C, 68.95; H, 6.19; N, 3.34.
b
1
Water
RT
RT
RT
80
360
240
240
300
150
180
130
85
–
–
–
–
b
b
b
2
Ethanol
Methanol
Water
2.5.6 3,3,6,6-Tetramethyl-9-(3-fluorophenyl)-3,4,6,7,9,10-
3
hexahydroacridine-1,8-dione (4p)
4
5
Ethanol
Methanol
78
75
Yellow solid; mp [300 ꢁC; IR (KBr): 3217, 3070, 2954,
6
64
67
1627 cm-1
;
7
Water?ethanol (2:1) 80
Water?ethanol (1:1) 80
63
1H NMR (300 MHz, DMSO-d6): d 9.19 (brs, 1H, NH),
7.64–7.48 (m, 3H, Ar–H), 7.26–7.24 (d, 1H, J = 6.6 Hz,
Ar–H), 5.53 (s, 1H, CH), 2.91–2.59 (m, 8H, CH2), 1.57 (s,
6H, CH3), 1.44 (s, 6H, CH3); 13C NMR (75 MHz, DMSO-
d6): d 190.5, 159.3, 144.7, 144.6, 144.4, 124.2, 124.1,
118.9, 110.0, 109.0, 107.0, 45.0, 53.0, 34.0, 28.0, 27.0,
23.0, 22.0; ESI–MS (m/z): 368 (M?H)?;
8
86
9
Acetone
60
80
80
80
180
120
110
135
300
240
120
180
20
10
11
12
13
14
15
16
Isopropyl alcohol
Glycerol
70
75
Acetonitrile
45
Dimethyl formamide 80
25
Dimethyl sulfoxide
[CMIM][CF3COO]
–
80
80
80
37
Anal. Calcd. for C23H26FNO2 (367.456): C, 75.18; H,
7.13; N, 3.81. Found: C, 75.25; H, 7.19; N, 3.87.
Trace
b
–
2.5.7 3,3,6,6-Tetramethyl-9-(3-pyridine)-3,4,6,7,9,10-
Reaction condition: dimedone (2 mmol), 4-OH benzaldehyde
(1 mmol), ammonium acetate (1.5 mmol), [CMIM][CF3COO]
(30 mol%)
hexahydroacridine-1,8-dione (4r)
a
Isolated yield
Light yellow solid; mp 298–300 ꢁC; IR (KBr): 3432, 3270,
b
3172, 2957, 1634 cm-1
;
No reaction
123